My previous investment thought on Brunswick Corporation (NYSE: BC ) was a hold rating because I was worried about the business's ability to grow despite some positive signals. For this update, I am downgrading to a sell. TheI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-te ...

The Trade Desk (TTD 0.93%) is scheduled to report quarterly financial results in early May, which could affect shareholders.*Stock prices used were the afternoon prices of April 23, 2025. The video was published on April 25, 2025. ...

New findings highlight impact of UNC13A genotype on treatment response in ALSNEW YORK, April 29, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, in collaboration with leading ALS research centers, today announced the acceptance of new pharmacogenomic data for oral presentation of new findings on NurOwn® at the International Society for Cell & Gene Therapy (ISCT) 2025 Annual Meeting, to take place from May 6 - 10 ...

SINGAPORE, April 29, 2025 /PRNewswire/ -- From April 21 to April 27, 2025, Mega Matrix Inc. (NYSE American: MPU) proudly presented eight English series on its global short drama platform, FlexTV. Each production offers a unique perspective on the universal struggles of contemporary life — from workplace trust issues to the delicate balance between love, ambition, and family, exploring the depths of human desires and conflicts. 404: Simp Not FoundOn the verge of bankruptcy, company owner Ethan stumbles upon ...

CLEVELAND, April 29, 2025 /PRNewswire/ -- Hyster-Yale, Inc. (NYSE: HY) announced today it will release its First Quarter 2025 financial results after the market closes on Tuesday, May 6, 2025.In conjunction with this release, the Company will host a webcast with the financial community at 11:00 a.m. ET on Wednesday, May 7, 2025, to discuss the financial results. Access to the live audio webcast will be available on the Company's website.To access the webcast, visit https://www.hyster-yale.com/investor-overv ...

Company affirms guidance and outlooksNEW ORLEANS, April 29, 2025 /PRNewswire/ -- Entergy Corporation (NYSE: ETR) reported first quarter 2025 earnings per share of 82 cents on an as-reported and an adjusted (non-GAAP) basis."We had a productive start to the year with progress on our key objectives," said Drew Marsh, Entergy Chair and Chief Executive Officer. "We are confident in the opportunity ahead as well as our ability to execute and deliver value on behalf of our customers and all stakeholders."Business ...

Conference Call Scheduled at 9am Eastern TimeAZOUR, Israel, April 29, 2025 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN), announced that it will be releasing its first quarter 2025 results on Wednesday, May 28, 2025.The Company will be hosting a video conference call later that day via Zoom, starting at 9am Eastern Time, 6am Pacific Time and 4pm Israel time. On the call, management will review and present the results and will be available to answer investor questions.To participate in the ...

Nvidia (NVDA -2.02%) has quickly risen from an obscure semiconductor company to become a household name. The company's success has mainly been driven by its skyrocketing data center sales, which have boomed as technology companies commit hundreds of billions of dollars to build the most advanced artificial intelligence (AI).The latest research from The Motley Fool shows that Nvidia easily leads the pack when it comes to data center sales, with $35.5 billion in the fourth quarter of 2024. For reference, Nvid ...

The growth reversion angle of Nvidia Corporation (NASDAQ: NVDA ) I used to write about previously executed my thesis much faster than expected. Meanwhile, the bearish noise makes NVDA stock trail behind its earnings growth performance. With this follow-up, I will touchAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opini ...

Urogen Pharma (URGN) shares ended the last trading session 14.1% higher at $11.26. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11.9% loss over the past four weeks.The stock rallied after the company presented multiple data at the annual meeting of the American Urological Association 2025 on its pipeline candidates that are being studied for different cancer indications.This company is expected to post quarterly ...